Monoclonal antibodies in cancer therapy

This publication has 20 references indexed in Scilit:

• Rational use of biological response modifiers in hematological malignancies—A review of treatment with interferon, cytotoxic cells and antibodies
  Leukemia Research, 1989
• Lymphokine Activated Killer (LAK) Cells in Antibody Dependent Cellular Cytotoxicity (ADCC) Using MAb 17-1A: A Combination of Potential Usefulness in Tumor Therapy
  Hybridoma, 1989
• Shared Idiotypes Expressed by Human B-Cell Lymphomas
  New England Journal of Medicine, 1989
• Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
  Science, 1989
• Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies
  JNCI Journal of the National Cancer Institute, 1989
• Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia
  Cancer Immunology, Immunotherapy, 1989
• An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin
  International Journal of Cancer, 1989
• REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
  The Lancet, 1988
• In Vivo Administration of Anti-CD3 Prevents Malignant Progressor Tumor Growth
  Science, 1988
• Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.
  Journal of Clinical Oncology, 1988